Procter & Gamble Stock Rises as Major Banks Raise Price Targets to $195
Shares in Procter & Gamble have climbed slightly today, trading 0.98% higher at $150.36. Several major banks, including JPMorgan Chase, Barclays, Deutsche Bank, UBS, and BNP Paribas Exane, have recently raised their price targets for the consumer goods giant, signalling growing confidence in its future performance. Over the past few weeks, multiple investment firms have lifted their forecasts for Procter & Gamble. JPMorgan Chase increased its target from $180 to $190 on 20 January 2026. Barclays followed on 15 January, raising its estimate from $175 to $185. Deutsche Bank also adjusted its outlook on 18 January, moving from $182 to $195. UBS boosted its target from $161 to $170 while keeping a 'buy' recommendation. BNP Paribas Exane raised its projection from $164 to $172, maintaining an 'outperform' rating. Analysts now predict the stock could reach around $168, suggesting an 11% upside from current levels. The optimism stems from expectations of faster revenue growth in the second half of fiscal 2026, driven by easier year-over-year comparisons and stronger consumer data from North America, as anticipated by Bank of America. The updated forecasts reflect confidence that Procter & Gamble can regain stronger growth and narrow the gap with competitors. However, some investors remain cautious, questioning whether the stock has already priced in these optimistic projections. The company’s performance in the coming months will determine whether further gains are possible.
